Dr. Castro will be a keynote speaker at the British Neuro-Oncology Society Annual Meeting July 5th-July 7th, 2023, in Manchester. Dr. Castro will be speaking on “Epigenetic reprogramming of the tumor microenvironment leads to enhanced DNA damage response and inhibition of immunosuppressive mechanisms in mutant IDH1 gliomas: clinical implications”. To register for conference, please click here.